Rang	Name	Position
1	Mr. Thomas E. Polen Jr.	President, CEO & Chairman
2	Dr. Michael D. Garrison	Executive VP & President of Medical Segment and BioPharma Systems Segments
3	Mr. Michael C. Feld	Executive VP & Chief Revenue Officer
4	Mr. Vitor Roque	Executive VP & CFO
5	Ms. Elizabeth McCombs	Executive VP & CTO
6	Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.	Senior VP & Chief Scientific Officer
7	Ms. Denise Russell Fleming	Executive Vice President & Chief Information Officer
8	Mr. Shawn C. Bevec	Senior Vice President of Investor Relations
9	Ms. Lanesha T. Minnix J.D.	Executive VP & General Counsel
10	Carla Burigatto	Senior VP & Chief Communications Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Arnhold & S. Bleichroeder Advisers, LLC	10,14%	4,91 Mrd. USD
2	BlackRock Inc	9,60%	4,65 Mrd. USD
3	Vanguard Capital Management, LLC	6,79%	3,29 Mrd. USD
4	Vanguard Portfolio Management, LLC	5,62%	2,72 Mrd. USD
5	State Street Corp	5,07%	2,46 Mrd. USD
6	Amvescap Plc.	3,74%	1,81 Mrd. USD
7	T. Rowe Price Investment Management,Inc.	3,56%	1,72 Mrd. USD
8	Massachusetts Financial Services Company	3,34%	1,62 Mrd. USD
9	Geode Capital Management, LLC	2,61%	1,26 Mrd. USD
10	Wellington Management Company LLP	2,33%	1,13 Mrd. USD
11	Greenhaven Associates Inc	2,09%	1,01 Mrd. USD
12	Franklin Templeton Inc	1,97%	0,95 Mrd. USD
13	T. Rowe Price Associates, Inc.	1,62%	0,79 Mrd. USD
14	NORGES BANK	1,53%	0,74 Mrd. USD
15	ClearBridge Advisors, LLC	1,52%	0,74 Mrd. USD
16	Morgan Stanley - Brokerage Accounts	1,48%	0,72 Mrd. USD
17	American Century Companies Inc	1,35%	0,65 Mrd. USD
18	JPMorgan Chase & Co	1,31%	0,64 Mrd. USD
19	Charles Schwab Investment Management Inc	1,22%	0,59 Mrd. USD
20	Bank of America Corp	0,98%	0,48 Mrd. USD